Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V9LF
|
|||
Former ID |
DIB012681
|
|||
Drug Name |
Anti-CD28
|
|||
Synonyms |
Anti-CD28 (immune disease); Anti-CD28 antibody (immune disorder), BMS; Anti-CD28 (immune disease), Bristol-Myers Squibb
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Immune System disease [ICD-11: 4A01-4B41; ICD-10: D80-D89] | Investigative | [1] | |
Company |
Bristol-Myers Squibb Co
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | T-cell-specific surface glycoprotein CD28 (CD28) | Target Info | . | [1] |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
T cell receptor signaling pathway | ||||
Intestinal immune network for IgA production | ||||
Type I diabetes mellitus | ||||
Measles | ||||
Autoimmune thyroid disease | ||||
Systemic lupus erythematosus | ||||
Rheumatoid arthritis | ||||
Allograft rejection | ||||
Graft-versus-host disease | ||||
Viral myocarditis | ||||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | T cell activation | |||
Pathway Interaction Database | TCR signaling in naï | |||
TCR signaling in naï | ||||
IL12 signaling mediated by STAT4 | ||||
Reactome | PIP3 activates AKT signaling | |||
Constitutive Signaling by Aberrant PI3K in Cancer | ||||
CD28 co-stimulation | ||||
CD28 dependent PI3K/Akt signaling | ||||
CD28 dependent Vav1 pathway | ||||
WikiPathways | TCR Signaling Pathway | |||
Inflammatory Response Pathway | ||||
Host Interactions of HIV factors | ||||
PIP3 activates AKT signaling | ||||
T-Cell Receptor and Co-stimulatory Signaling | ||||
Allograft Rejection | ||||
Costimulation by the CD28 family |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2863). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.